GOLDENTREE ASSET MANAGEMENT LP
SEC insider (Form 3/4/5 filer). CIK 0001278951. 10% Owner at Keenova Therapeutics plc (NONE) and 2 other issuers. 45 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in NEW YORK, NY.
Companies GOLDENTREE ASSET MANAGEMENT LP has filed insider reports for
- Keenova Therapeutics plc (NONE): 10% Owner
- QVC Group, Inc. (QVCG): 10% Owner
- GoldenTree Opportunistic Credit Fund (NONE): 10% Owner
GOLDENTREE ASSET MANAGEMENT LP
CIK: 0001278951
Transaction Breakdown
Open Market Buys (P)42 (93.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (6.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (45 total)
- Oct 14, 2026No ticker
Keenova Therapeutics plc
PurchaseIndirect137K shares at avg. $90.00$12.3M - Oct 9, 2026QVCG
QVC Group, Inc.
PurchaseIndirect1.4M shares at avg. $12.35$16.7M - Oct 2, 2026QVCG
QVC Group, Inc.
PurchaseIndirect250K shares at avg. $13.85$3.5M - Oct 1, 2026QVCG
QVC Group, Inc.
PurchaseIndirect2K shares at avg. $13.63$28K - Oct 1, 2026QVCG
QVC Group, Inc.
PurchaseIndirect848 shares at avg. $13.61$12K - Sep 30, 2026QVCG
QVC Group, Inc.
PurchaseIndirect2.9K shares at avg. $13.61$40K - Sep 24, 2026No ticker
Keenova Therapeutics plc
PurchaseIndirect463K shares at avg. $91.00$42.1M - Sep 24, 2026QVCG
QVC Group, Inc.
PurchaseIndirect80K shares at avg. $14.35$1.1M - Sep 8, 2026QVCG
QVC Group, Inc.
PurchaseIndirect1.6M shares at avg. $16.25$26.0M - Sep 3, 2026QVCG
QVC Group, Inc.
PurchaseIndirect720K shares at avg. $16.45$11.8M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 14, 2026 |  No ticker Keenova Therapeutics plc | Purchase | 137,000 | $90.00 | $12,330,000 | Indirect |
| Oct 9, 2026 |  QVCG QVC Group, Inc. | Purchase | 1,352,000 | $12.35 | $16,697,200 | Indirect |
| Oct 2, 2026 | QVCG QVC Group, Inc. | Purchase | 250,000 | $13.85 | $3,462,500 | Indirect |
| Oct 1, 2026 | QVCG QVC Group, Inc. | Purchase | 2,024 | $13.63 | $27,579 | Indirect |
| Oct 1, 2026 | QVCG QVC Group, Inc. | Purchase | 848 | $13.61 | $11,539 | Indirect |
| Sep 30, 2026 | QVCG QVC Group, Inc. | Purchase | 2,907 | $13.61 | $39,574 | Indirect |
| Sep 24, 2026 | No ticker Keenova Therapeutics plc | Purchase | 463,000 | $91.00 | $42,133,000 | Indirect |
| Sep 24, 2026 | QVCG QVC Group, Inc. | Purchase | 80,000 | $14.35 | $1,148,000 | Indirect |
| Sep 8, 2026 | QVCG QVC Group, Inc. | Purchase | 1,600,000 | $16.25 | $26,000,000 | Indirect |
| Sep 3, 2026 | QVCG QVC Group, Inc. | Purchase | 720,000 | $16.45 | $11,844,000 | Indirect |
1-10 of 45 transactions